非处方他汀类药物。 - Suppr

Suppr

超能文献

Over-the-counter statins.

作者信息

Malik Nafees N

出版信息

Lancet. 2004;364(9432):411. doi: 10.1016/S0140-6736(04)16750-0.

DOI:10.1016/S0140-6736(04)16750-0

PMID:15288726

Abstract

摘要

相似文献

Over-the-counter statins.

Lancet. 2004;364(9432):411. doi: 10.1016/S0140-6736(04)16750-0.

Over-the-counter statins.

Lancet. 2004;364(9432):411-2. doi: 10.1016/S0140-6736(04)16751-2.

Over-the-counter statins and cardiovascular disease prevention: perspectives, challenges, and opportunities.

Clin Pharmacol Ther. 2005 Sep;78(3):213-7. doi: 10.1016/j.clpt.2005.05.013.

[Over-the-counter statins: benefit or harmful?].

Rev Med Suisse. 2005 Oct 26;1(38):2447-8, 2451-2.

Primary prevention with over-the-counter statins: a cautionary tale.

Clin Pharmacol Ther. 2005 Sep;78(3):218-20. doi: 10.1016/j.clpt.2005.06.001.

Impact of a policy allowing for over-the-counter statins.

Qual Prim Care. 2010;18(5):301-6.

Simvastatin over the counter.

Drug Ther Bull. 2005 Apr;43(4):25-8. doi: 10.1136/dtb.2005.43425.

Understanding the implications of over the counter statin sales.

Nurs Times. 2004;100(21):28-9.

Merck's statin first to receive over-the-counter status.

Nat Rev Drug Discov. 2004 Jul;3(7):542-3. doi: 10.1038/nrd1463.

Reclassification of simvastatin to over-the-counter status in the United Kingdom: a primary prevention strategy.

Am J Cardiol. 2004 Nov 4;94(9A):35F-39F. doi: 10.1016/j.amjcard.2004.07.053.

引用本文的文献

The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications.

Drug Saf. 2005;28(8):659-76. doi: 10.2165/00002018-200528080-00002.

Direct to consumer marketing: switch to over the counter can become indirect advertising directly to consumers.

BMJ. 2005 Apr 16;330(7496):906. doi: 10.1136/bmj.330.7496.906-a.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Over-the-counter statins.

Lancet. 2004;364(9432):411. doi: 10.1016/S0140-6736(04)16750-0.

Over-the-counter statins.

Lancet. 2004;364(9432):411-2. doi: 10.1016/S0140-6736(04)16751-2.

Over-the-counter statins and cardiovascular disease prevention: perspectives, challenges, and opportunities.

Clin Pharmacol Ther. 2005 Sep;78(3):213-7. doi: 10.1016/j.clpt.2005.05.013.

[Over-the-counter statins: benefit or harmful?].

Rev Med Suisse. 2005 Oct 26;1(38):2447-8, 2451-2.

Primary prevention with over-the-counter statins: a cautionary tale.

Clin Pharmacol Ther. 2005 Sep;78(3):218-20. doi: 10.1016/j.clpt.2005.06.001.

Impact of a policy allowing for over-the-counter statins.

Qual Prim Care. 2010;18(5):301-6.

Simvastatin over the counter.

Drug Ther Bull. 2005 Apr;43(4):25-8. doi: 10.1136/dtb.2005.43425.

Understanding the implications of over the counter statin sales.

Nurs Times. 2004;100(21):28-9.

Merck's statin first to receive over-the-counter status.

Nat Rev Drug Discov. 2004 Jul;3(7):542-3. doi: 10.1038/nrd1463.

Reclassification of simvastatin to over-the-counter status in the United Kingdom: a primary prevention strategy.

Am J Cardiol. 2004 Nov 4;94(9A):35F-39F. doi: 10.1016/j.amjcard.2004.07.053.

引用本文的文献

The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications.

Drug Saf. 2005;28(8):659-76. doi: 10.2165/00002018-200528080-00002.

Direct to consumer marketing: switch to over the counter can become indirect advertising directly to consumers.

BMJ. 2005 Apr 16;330(7496):906. doi: 10.1136/bmj.330.7496.906-a.